Free-cash-flow proxy decreased 112.4%
Free-cash-flow proxy changed -112.4% from the comparable as-filed period.
-$2.7B→-$5.7B1 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →CRWV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 349 bp lower
Operating margin changed -349 basis points from the comparable as-filed period.
1.58%→-1.90%0 prior comparisons
Revenue increased 112.3%
Revenue changed +112.3% from the comparable as-filed period.
$1.2B→$2.6B0 prior comparisons
Cash & equivalents increased 379.1%
Cash & equivalents changed +379.1% from the comparable as-filed period.
$1.2B→$5.5B0 prior comparisons
Capital expenditure increased 161.8%
Capital expenditure changed +161.8% from the comparable as-filed period.
$2.5B→$6.4B1 prior comparisons
Current assets increased 141.3%
Current assets changed +141.3% from the comparable as-filed period.
$3.9B→$9.5B1 prior comparisons
Current liabilities increased 176.8%
Current liabilities changed +176.8% from the comparable as-filed period.
$7.6B→$20.9B1 prior comparisons
Total assets increased 193.7%
Total assets changed +193.7% from the comparable as-filed period.
$26.2B→$77.1B1 prior comparisons
Trade receivables increased 31.4%
Trade receivables changed +31.4% from the comparable as-filed period.
$1.9B→$2.5B1 prior comparisons
Working capital decreased 215.7%
Working capital changed -215.7% from the comparable as-filed period.
-$3.6B→-$11.4B1 prior comparisons
Capex / revenue moved 4714 bp higher
Capex / revenue changed +4714 basis points from the comparable as-filed period.
202.26%→249.40%0 prior comparisons
Research & development increased 46.2%
Research & development changed +46.2% from the comparable as-filed period.
$80.0M→$117.0M0 prior comparisons
Operating cash flow changed across a sign change
Operating cash flow changed +370.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$251.3M→$679.0M1 prior comparisons
SBC / revenue moved 555 bp lower
SBC / revenue changed -555 basis points from the comparable as-filed period.
11.96%→6.41%0 prior comparisons
Operating cash-flow margin moved 4709 bp higher
Operating cash-flow margin changed +4709 basis points from the comparable as-filed period.
-20.72%→26.37%0 prior comparisons
Operating income changed across a sign change
Operating income changed -355.1% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
$19.2M→-$49.0M0 prior comparisons
Receivables / revenue moved 6076 bp lower
Receivables / revenue changed -6076 basis points from the comparable as-filed period.
159.44%→98.68%0 prior comparisons
R&D / revenue moved 205 bp lower
R&D / revenue changed -205 basis points from the comparable as-filed period.
6.60%→4.54%0 prior comparisons
Current ratio decreased 12.8%
Current ratio changed -12.8% from the comparable as-filed period.
0.52→0.461 prior comparisons
Stock-based compensation increased 13.8%
Stock-based compensation changed +13.8% from the comparable as-filed period.
$145.0M→$165.0M0 prior comparisons
Working capital / assets moved 103 bp lower
Working capital / assets changed -103 basis points from the comparable as-filed period.
-13.76%→-14.79%1 prior comparisons
Free-cash-flow margin moved 5 bp lower
Free-cash-flow margin changed -5 basis points from the comparable as-filed period.
-222.98%→-223.03%0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.